| 09.09.2024 16:46 | IMM | ImmuPharma narrows losses in first half as expenses fall | Alliance |
| 09.09.2024 12:45 | IMM | ImmuPharma obtains second warrant extension with Incanthera | Alliance |
| 09.09.2024 07:01 | IMM | Extension of Warrants in Incanthera to 31 Mar 2025 | RNS |
| 09.09.2024 07:00 | IMM | Half-year Report | RNS |
| 06.08.2024 13:41 | IMM | Holding(s) in Company | RNS |
| 28.06.2024 12:17 | IMM | Result of AGM | RNS |
| 21.06.2024 15:18 | ZEG, XLM, VLE | UK shareholder meetings calendar - next 7 days | Alliance |
| 06.06.2024 16:20 | IMM | Holding(s) in Company | RNS |
| 05.06.2024 16:32 | EEE, FIN, RTC | EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows | Alliance |
| 05.06.2024 14:01 | IMM | Notice of AGM & Annual Report & Accounts | RNS |
| 05.06.2024 07:00 | IMM | Final Results | RNS |
| 03.06.2024 10:09 | IMM | Realisation-c£1.5m on sale of shares in Incanthera | RNS |
| 03.05.2024 07:00 | IMM | Holding(s) in Company | RNS |
| 24.04.2024 07:12 | IMM | IMMUPHARMA AT BIO-EQUITY 2024 12-14 May | Reach |
| 19.04.2024 07:00 | IMM | Grant of Share Options | RNS |
| 02.04.2024 12:52 | IMM | Immupharma jumps amid new IP strategy for P140 technology platform | Alliance |
| 02.04.2024 07:03 | IMM | New intellectual property strategy initiated | RNS |
| 25.03.2024 12:20 | IMM | Incanthera says first order from skincare deal doubles | Alliance |
| 25.03.2024 10:55 | AEO, IMM, CASP | AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss | Alliance |
| 25.03.2024 07:25 | IMM | Incanthera provides Comm'l Update/Revenue F'casts | RNS |
| 19.03.2024 07:00 | IMM | Grant of Share Options | RNS |
| 14.03.2024 07:00 | IMM | IMMUPHARMA AT BIO-EUROPE SPRING 2024 | Reach |
| 06.03.2024 13:05 | NET, RCDO, AEG | EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up | Alliance |
| 06.03.2024 07:00 | IMM | Financial, Business and Portfolio Develop't Update | RNS |
| 28.12.2023 13:35 | IMM | Holding(s) in Company | RNS |
| 19.12.2023 17:52 | PCIP, IMM, TIME | EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows | Alliance |
| 19.12.2023 14:50 | IMM | Holding(s) in Company | RNS |
| 19.12.2023 07:00 | IMM | Simbec-Orion appointed as CRO | RNS |
| 18.12.2023 12:18 | IMM | IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million | Alliance |
| 18.12.2023 07:15 | IMM | Incanthera - Comm'l Skincare Deal/£1M Fundraise | RNS |
| 13.09.2023 15:47 | IMM | Holding(s) in Company | RNS |
| 07.09.2023 17:07 | RAI, CGI, AREC | TRADING UPDATES: RA International loss narrows as revenue grows | Alliance |
| 07.09.2023 07:00 | IMM | Result of Retail Offer and Director Shareholding | RNS |
| 06.09.2023 13:53 | IMM | Holding(s) in Company | RNS |
| 31.08.2023 13:05 | IMM | ImmuPharma launches GBP2 million fund raise as interim loss narrows | Alliance |
| 31.08.2023 07:02 | IMM | WRAP Retail Offer for up to £0.5m | RNS |
| 31.08.2023 07:01 | IMM | Subscription to raise £1.35m; Sharing Agr, RPT | RNS |
| 31.08.2023 07:00 | IMM | Interim results | RNS |
| 21.08.2023 12:33 | IMM | ImmuPharma agrees 12 month extension to Incanthera warrant instrument | Alliance |
| 21.08.2023 07:00 | IMM | Extension of warrants in Incanthera plc | RNS |
| 11.08.2023 12:04 | IMM | Directorate Change | RNS |
| 30.06.2023 13:12 | IMM | Result of AGM | RNS |
| 23.06.2023 15:51 | CHSS, STG, SAVE | UK shareholder meetings calendar - next 7 days | Alliance |
| 19.06.2023 12:02 | IMM | IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial | Alliance |
| 19.06.2023 07:00 | IMM | Lupuzor Update | RNS |
| 06.06.2023 07:00 | IMM | IMM RNS Posting of RA and Notice of AGM 30 June 23 | RNS |
| 18.05.2023 12:12 | IMM | IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease | Alliance |
| 18.05.2023 07:00 | IMM | Positive Pre-IND meeting with FDA | RNS |
| 11.05.2023 11:48 | IMM | IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced | Alliance |
| 10.05.2023 13:56 | IMM | Holding(s) in Company | RNS |
| 19.04.2023 15:40 | IMM | IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting | Alliance |
| 19.04.2023 07:00 | IMM | Lupozor Update - FDA confirms Type-C meeting date | RNS |
| 12.04.2023 11:27 | IMM | IN BRIEF: ImmuPharma shares up as FDA meeting for new drug confirmed | Alliance |
| 12.04.2023 10:37 | SYS1, IMM, BZT | AIM WINNERS & LOSERS: System1 rises after upturn in second half | Alliance |
| 12.04.2023 07:00 | IMM | CIDP P140 Clinical Program Update | RNS |
| 27.03.2023 10:51 | IMM, PRES | AIM WINNERS & LOSERS: ScotGold drops two-thirds as gold grade declines | Alliance |
| 27.03.2023 10:32 | IMM | ImmuPharma submits phase 2/3 protocol to US FDA for Lupuzor treatment | Alliance |
| 27.03.2023 07:00 | IMM | Lupuzor™ Update | RNS |
| 09.03.2023 16:35 | IMM | Price Monitoring Extension | RNS |
| 06.03.2023 11:22 | IMM | ImmuPharma signs 12-month deal with Orano for use of peptide tech | Alliance |
| 06.03.2023 07:00 | IMM | Collaboration with Orano on ImmuPharma Peptide | RNS |
| 06.02.2023 11:37 | IMM | ImmuPharma agrees study design with Avion for lupus programme Lupuzor | Alliance |
| 06.02.2023 07:00 | IMM | Lupuzor™ Update | RNS |
| 27.01.2023 16:25 | IMM | TR-1: Notification of major holdings | RNS |
| 04.01.2023 17:26 | IMM | TR-1: Notification of major holdings | RNS |
| 04.01.2023 16:40 | IMM | Second Price Monitoring Extn | RNS |
| 04.01.2023 16:35 | IMM | Price Monitoring Extension | RNS |
| 03.01.2023 16:58 | IMM | TR-1: Notification of major holdings | RNS |
| 22.12.2022 21:09 | ICON, POW, IMM | TRADING UPDATES: Ground Rents Income Fund's portfolio value drops | Alliance |
| 22.12.2022 07:55 | IMM | Grant of Options | RNS |
| 22.12.2022 07:00 | IMM | End of Year Update | RNS |
| 22.11.2022 15:15 | IMM | Holding(s) in Company | RNS |
| 14.11.2022 16:40 | IMM | Second Price Monitoring Extn | RNS |
| 14.11.2022 16:35 | IMM | Price Monitoring Extension | RNS |
| 11.11.2022 19:56 | IUG, SLFR, CCZ | TRADING UPDATES: Driver records loss; Synectics sells business unit | Alliance |
